The Food and Drug Administration on Friday approved two gene therapies to treat sickle cell disease, one of the which is the first CRISPR/Cas9-based treatment to win regulatory approval in the US. The ...
Researchers have been able to manipulate large chunks of genetic code for almost 50 years. But it is only within the past decade that they have been able to do it with exquisite precision – adding, ...
CRISPR Therapeutics recently obtained approval for its gene therapy Casgevy. The therapy could generate close to $4 billion in annual revenue at its peak. A product approval and strong balance sheet ...
Hosted on MSN
How CRISPR works, explained in two minutes
An explanation of how the cutting-edge gene editing tool works. Sweeping ICE Arrests in Blow to Immigration Crisis Dramatic video shows Royal Navy warship HMS Dragon shooting down supersonic missile ...
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...
CRISPR Therapeutics (NASDAQ: CRSP) has put itself on the map of the healthcare industry as a serious player in gene editing. Now that it has an approved treatment in Casgevy, there's undoubtedly going ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback